— Know what they know.
Not Investment Advice

BLFE OTC

BioLife Sciences Inc.
1W: -99.0% 1M: -99.0% 3M: -99.0% YTD: -99.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 47 · $156683 mcap · 1.13B float · 0.0067% daily turnover · Short 60% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range0.0001-0.01
Volume911
Avg Volume75,525
Beta-2290.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJustin De Four
Employees3
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2005-04-25
2831 Saint Rose Parkway
Henderson, NV 89052
US
833-919-1037
About BioLife Sciences Inc.

BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, ultraviolet (UV) sterilization equipment, professional electrostatic disinfection services, specialized anti-microbial fabrics, and innovative touch-free vending or marketplace systems. The company, which was established in 2018, operates from its base in Mississauga, Canada.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms